Nafarelin in the treatment of infertility caused by endometriosis.
Patients with infertility caused by endometriosis may be managed by expectant strategies, surgery, or pharmacologic intervention. The relative benefits conferred by each of these approaches remain to be confirmed. Data gathered thus far suggest, however, that nafarelin, a gonadotropin-releasing hormone agonist, may be associated with fecundity rates as low as those seen after surgical intervention.
Barlow
D H
DH
Nuffield Department of Obstetrics and Gynecology, University of Oxford, United Kingdom.
D003613:Danazol / Q000627:therapeutic use; D004715:Endometriosis / Q000150:complications / Q000188:drug therapy*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D017274:Nafarelin; D011247:Pregnancy
D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone; D003613:Danazol